baber/WOPTO huggingface dataset:
Patent NZ-536569-A (NZ)
Title: Safety shield for medical needles
Inventor: FERGUSON F MARK
IPC: A61G12/00
Filed: 2003-07-14
Abstract: A medical needle shield apparatus (10) is provided which is slidably movable along a medical needle (16) from a proximal position where a distal end of the needle is exposed, to a distal position where the shield protects the distal end of the needle. The medical needle shield apparatus includes a binding member (18) having an aperture through which the needle passes. The binding member also has binding surfaces (22) for binding to a medical needle. The shield apparatus also includes a retainer (24) integral with the binding member and in communication with the needle for temporarily retaining the binding surfaces in a non-binding position relative to the needle. The shield apparatus also includes a positioning member (26) comprising one or more friction elements (48) disposed on the needle for positioning the binding surfaces to secure the shield to the needle when a portion of the retainer (36) in contact with the needle is advanced past the distal end of the needle.
Patent NZ-537461-A (NZ)
Title: A safety system
Inventor: DAVIES KEVIN STEPHEN
IPC: F16P3/14
Filed: 2003-06-10
Abstract: A safety system for use with a machine having a moving tool arranged to move through a known path of movement. The safety system is arranged to detect the presence of an obstruction in a region (20) around a portion of said path deemed to be hazardous. The safety system is characterised by comprising a light emitting means (16), a light receiving means (18) and a processing and control means. The light emitting means (16) is arranged to emit light generally parallel to the path of movement of the tool such that the region (20) is illuminated. The light receiving means (18) is arranged to receive light from the light emitting means (16) which has passed through the region (20). The processing and control means is arranged to receive information from the light receiving means (18) and determine whether an obstruction exists in the region (20) by the presence of one or more shadow regions cast on the light receiving means (18) by the obstruction and to control movement of the tool (12) dependent on the presence of obstructions in the region (12).
Patent NZ-541622-A (NZ)
Title: Method and system for administering a drug
Inventor: SHANNON ROBERT W J
IPC: G16Z99/00
Filed: 2004-03-04
Abstract: A method for administering a drug is provided. The method includes receiving information concerning a therapeutic break period of a drug. The therapeutic break period indicates a predicted range of time when the drug will reach a pre-determined level of effectiveness for a patient. The method also includes identifying a date range that corresponds to the therapeutic break period, and graphically displaying an indication of the therapeutic break period in conjunction with the date range for at least one dosage of the drug.
Patent NZ-543442-A (NZ)
Title: Protective helmets
Inventor: SPINK GLEN ERNEST
Filed: 2005-11-07
Abstract: A protective helmet assembly, having a protective shell (1) with a head cradle system (2) as wearable head support therefor, is disclosed. The assembly is characterised in that the protective shell (1), as a Level 1 shell, is enhanced by at least one additional shell (8, 9) (i.e. Level 2 and so forth) carried directly or indirectly. Each shell has at least one formation interengageable with a complementary at least one formation of the underlying shell, where the interengagement is a friction and/or interference fit formation to formation.
Patent NZ-546560-A (NZ)
Title: Water drain device for a sliding door frame
Inventor: LEWIS WARREN PAUL
Filed: 2006-04-13
Abstract: A drainage system for a sliding door floor channel consisting of a hollow water tight casing 14 attached to a drain outlet in the floor channel. The casing has a bottom opening 10 a certain distance below the drain outlet 8, with a cross-sectional area smaller than of the casing so that water can collect inside it and form a water head.
Patent NZ-547071-A (NZ)
Title: Preparation of palladium / gold catalyst on a support when prepared from halide free precursors
Inventor: WANG TAO
IPC: B01J21/06
Filed: 2004-11-19
Abstract: Disclosed is a method of producing a catalyst or pre-catalyst suitable for assisting in the production of alkenyl alkanoates (such as vinyl acetate), comprising: a) contacting at least one catalytic precursor solution comprising palladium and gold to a support material wherein the at least one catalytic precursor solution is an aqueous solution that comprises one or more of Pd(NH3)2(NO2)2, Pd(NH3)4(OH)2, Pd(NH3)4(NO3)2, Pd(NH3)4(OAc)2, Pd(NH3)2(OAc)2, Pd(NH3)2(HCO3)2, NaAuO2, NMe4AuO2, HAu(NO3)4 in nitric acid or combinations thereof, wherein the aqueous solution is substantially free of chlorine; and b) reducing the palladium or gold by contacting a reducing environment to the support material.
Patent NZ-547629-A (NZ)
Title: Antibodies binding to conformationally discriminating epitopes of human IGG Fc receptor IIb and IIb
Inventor: HUBER ROBERT
IPC: C07K14/735
Filed: 2004-11-26
Abstract: Disclosed is an antibody or fragment thereof, which specifically binds to either human FcgammaRllb or FcgammaRlla in the natural environment of the Fc receptor and which is capable of binding to a conformationally discriminating epitope (CDE) of human FcyRllb or FcyRlla, wherein the CDE comprises at least one of amino acids 12, 27, 29, 30, 104, 127, 132, 135, 160 and 171 of the amino acid sequence of FcgammaRIlb or FcgammaRIla according to SEQ ID NO: 1 or SEQ ID NO: 2.
Patent NZ-548958-A (NZ)
Title: Method for buying and selling real estate
Inventor: ARNALL LEIGH RAYMOND
Filed: 2006-08-07
Abstract: An internet-based system for exchanging the ownership of a property between a first party desirous of selling the property and at least one second party desirous of buying the property in return for valuable consideration comprises an internet site, and software operable to control the operation of the site and to facilitate communication between a the first party, at second party, and an agent acting for all parties. The internet site and the software together allows the first party to access the internet to sell the right to make known to at least one other party that the property is for sale, neither the first party nor the agent indicating an expectation of the valuable consideration; the agent to make known to the second party that the property is for sale by placing a notice on the internet site, neither the second party nor the agent indicating an expectation of the valuable consideration; the second party to access the internet site to provide consent to the agent to act on their behalf in buying the property; the second party to access the internet site to make a secret bid for the property during a predetermined period of time and the first party to access the internet site to inspect the secret bid or bids at the conclusion of the predetermined period of time, and the first party to accept or refuse the bid or bids by indicating this on the internet site to the agent and the second party. A bid includes a transaction fee nominated by the agent and to be paid to the agent by the second party if the bid is successful, and the valuable consideration the second party is prepared to pay to the first party to purchase the property. Addition to 532114
Patent NZ-549214-A (NZ)
Title: Sterilisation apparatus
Inventor: FRAUNDORFER MARK ROBERT
Filed: 2006-08-15
Abstract: A sterilisation apparatus with a base tray (2) and a lid (4) for the disinfection of surgical equipment. The base tray has an inner sterilisation compartment (11) and an outer spill compartment (12) separated by an internal wall (13) which is lower than the outer base tray wall (14). The sterilisation compartment (11) has guides (15 and 16) for positioning a flexible endoscope with excess cable length able to extend outside of the apparatus through a cable exit (23). The sterilisation compartment (11) and the spill compartment (12) are connected to drains (10 and 10A) which are connected through a control device (not shown) to a drain.
Patent NZ-554469-A (NZ)
Title: Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
Inventor: FELICETTI PATRIZIA
IPC: A61K31/47
Filed: 2005-09-27
Abstract: Provided is the compound (4-(S)-amino-5-(4- {4-[2,4-dichloro-3-(2,4-dimethyl-quinolin-8-yloxymethyl)benzenesulfonylamino] tetrahydropyran-4-carbonyl}piperazin-1-y1)-5-oxopentyl] trimethyl-ammonium chloride, dihydrochloride and related compounds, and their use in the manufacture of medicament for the treatment of inflammatory, allergic or autoimmune conditions.
Patent NZ-554998-A (NZ)
Title: Footwear closure device
Inventor: SAUSMAN ANGELA LESLEY
Filed: 2005-10-19
Abstract: A device for protecting the interior of footwear from the environment when the footwear is not in use, including a cover 5 and expansion means 10, the expansion means 10 including at least one resiliently biased member for releasable engagement with an interior wall of the footwear, whereby the engagement with an interior wall causes the footwear to adopt a shape substantially corresponding to the shape of the footwear when in use, the cover 5 including a moisture impervious portion 20 and a sealing means 25 for forming a snug fit between the cover 5 and an exterior surface of the footwear.
Patent NZ-556408-A (NZ)
Title: Rinsable metal pretreatment methods and compositions
Inventor: RODZEWICH EDWARD A
IPC: C23C22/34
Filed: 2006-01-05
Abstract: Disclosed is a method of coating a metal or metal alloy surface comprising contacting said surface with an effective amount of a chromate free aqueous treatment solution or dispersion comprising (a) a material or materials comprising one or more elements selected from Group IV B elements; (b) fluoride; (c) phosphonic acid or phosphonate selected from the group consisting of the formulas II, III or IV wherein the substituents are as defined in the specification and (d) silane provided that the solution does not comprise tannins.
Patent NZ-562534-A (NZ)
Title: Carton formed from a blank with an internal shoulder to support contained items
Inventor: GOMES JEAN-MANUEL
IPC: B65D5/54
Filed: 2006-04-17
Abstract: A carton made from a single blank with an internal shoulder to support a plurality of items is disclosed. The internal shoulder is provided along the entire length of the carton and in use supports the tops (T) of the items inside. Such items may be wine bottles. A handle and a frangible opening may also be provided as part of the blank.
Patent NZ-566044-A (NZ)
Title: Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field
Inventor: NACCARI GIANCARLO
IPC: A61K31/136
Filed: 2006-07-24
Abstract: Disclosed is a compound of the general formula (I) e.g. 4-amino-N-hydroxy-2-methoxybenzamide, 5-amino-N-hydroxy-2-methoxybenzamide, 5-amino-2,3-dihydrobenzofuran-7-carboxylic acid, 5-amino-2-ethoxy-N-hydroxybenzamide, 5-amino-2-isopropoxybenzoic acid and 5-diisopropylaminosalicylic acid in which the variables are defined in the specification for the treatment of cancer or an inflammatory disease.
Patent NZ-570645-A (NZ)
Title: Method of promoting thickening growth of agricultural or horticultural crop
Inventor: ITAI AKIHIRO
IPC: A01N25/04
Filed: 2007-01-23
Abstract: Disclosed is a method of enlarging fruit comprising applying gibberellin and a cyclohexane derivative of formula (I).
Patent NZ-572836-A (NZ)
Title: Iap bir domain binding compounds
Inventor: LAURENT ALAIN
IPC: G01N33/566
Filed: 2007-05-16
Abstract: Disclosed is an amide compound of formula (I) which contains a pyrrolidine ring or a fused pyrrolidine ring. Also disclosed is a process for synthesising a compound of formula (I), an intermediate used in the process for making a compound of formula (I), a pharmaceutical composition comprising a compound of formula (I), a method for preparing a pharmaceutical composition, a method of modulating IAP function in vitro with a compound of formula (I) and the use of a compound of formula (I) for the manufacture of a medicament for treating a diseases state characterized by insufficient apoptosis or a proliferative disorder.
Patent NZ-580738-A (NZ)
Title: Process for the preparation of escitalopram
Inventor: BIDARI DILIP RAMDAS
IPC: C07D307/87
Filed: 2008-05-16
Abstract: Disclosed is a process for forming a compound of formula (III) comprising demethylating citalopram of formula (IV) using 1-chloroethylchloroformate in the presence of a base to form a carbamate intermediate followed by cleavage of the carbamate to yield the intermediate compound (III). Also disclosed is the process of preparing a compound of formula (II) by resoling a racemic mixture of compound (III) with a resolving agent. Further disclosed is a process for preparing escitalopram and the escitalopram prepared by that method.
Patent NZ-583538-A (NZ)
Title: Pyridin-2-yl-amino-1,2,4 -thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
Inventor: GUNAWARDANA INDRANI W
IPC: A61K31/433
Filed: 2008-09-15
Abstract: The disclosure relates to compounds of formula (I): wherein R2, R3, R13, L and D2 are as defined in the specification, which are useful in the treatment and/or prevention of diseases or disorders mediated by deficient levels of glucokinase activity or which can be treated by activating glucokinase including, but not limited to, diabetes mellitus, impaired glucose tolerance, IFG (impaired fasting glucose) and IFG (impaired fasting glycemia), as well as other diseases and disorders such as those discussed in the specification.
Patent NZ-585072-A (NZ)
Title: Treatment of neurological disorders
Inventor: MORLEY GRANT
IPC: C01B19/00
Filed: 2008-10-03
Abstract: Provided is the use of selenite or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment or prevention of a non-tauopathy neurological disorder selected from the group consisting of stroke, cerebral ischaemia, dementia associated with stroke or cerebral ischaemia, dementia associated with HIV, disorders associated with excitotoxicity, epilepsy, seizures, schizophrenia, acute brain trauma (traumatic brain injury) and oxygen glucose deprivation.
Patent NZ-585814-A (NZ)
Title: Polysaccharide gel formulation
Inventor: STROUMPOULIS DIMITRIOS
IPC: A61K8/73
Filed: 2008-11-24
Abstract: Described herein are polysaccharide gel formulations including at least one inhibitor of polysaccharide degradation and methods of making the same. The methods described herein involve the steps of providing at least one polysaccharide and incorporating at least one inhibitor of degradation into the polysaccharide. In some embodiments, the incorporating step comprises 1 ) mixing the at least one inhibitor with the at least one polysaccharide at a highly hydrated state thereby encapsulating the at least one inhibitor in a polysaccharide network, and 2) dehydrating the polysaccharide network thereby controlling release kinetics or final swell ratio. In another embodiment, the incorporating step comprises 1) encapsulating at least one inhibitor into a biocompatible or biodegradable vessel and 2) combining the polysaccharide and the vessel into a gel formulation. The polysaccharide gel formulations described herein can be used for a variety of cosmetic applications.
Patent NZ-587477-A (NZ)
Title: Broccoli hybrid ps05151639
Inventor: MERO CARL E
IPC: A23L19/00
Filed: 2010-08-20
Abstract: Disclosed is a seed or broccoli plant comprising at least a first set of the chromosomes of broccoli line BRM 51-1162, a sample of seed of said lines having been deposited under ATCC Accession Number PTA-9675. Further disclosed is a broccoli floret comprising an endogenous content of MSB (glucoraphanin) and MSP (glucoiberin) present in a ratio of MSB to MSP of about 2:1 on a weight to weight basis or from about 2.4X to about 3.5X the MSB content of a standard broccoli variety.
Patent NZ-588190-A (NZ)
Title: Separating prion proteins with polyglycidyl methacrylate surface modified matrix
Inventor: CARBONELL RUBIN G
IPC: C12Q1/68
Filed: 2005-06-09
Abstract: A device for separating prion protein from a sample, the device comprising one or more porous matrices having pore sizes greater than 10 micrometres. The one or more porous matrices are surface modified with polyglycidyl methacrylate (PGMA).
Patent NZ-588690-A (NZ)
Title: Antisapstain compositions comprising a haloalkynyl compound, an azole and an unsaturated acid
Inventor: WARBURTON PAUL STUART
IPC: A01N37/06
Filed: 2009-04-30
Abstract: Disclosed is an antisapstain composition comprising a haloalkynyl compound, an azole and an unsaturated carboxylic acid, alkali metal salt or alkaline earth metal salt thereof. A specific example of a haloalkynyl compound is 3-iodo-2-propynyl butyl carbamate (IPBC). Specific examples of an unsaturated carboxylic acid are sorbic acid, sodium sorbate, potassium sorbate, myristoleic acid, palmitoleic acid, oleic acid, elaidic acid, linoleic acid, alinolenic acid, arachidonic acid, eicosapentaenoic acid, euric acid, docosahexanoic acid, fumaric acid, maleic acid and maleic anhydride. Specific examples of the azole include substituted imidazoles and 1,2,4-triazoles. The antisapstain compositions are useful for treating wood and other cellulosic materials and protecting substrates against moulds, staining and other defacing organisms.
Patent NZ-590212-A (NZ)
Title: Methods and apparatus for the systemic control of ventilatory support in the presence of respiratory insufficiency
Inventor: BASSIN DAVID JOHN
IPC: A61H31/00
Filed: 2004-11-25
Abstract: Apparatus for providing ventilatory assistance to a spontaneously breathing patient comprises processing means for computing a measure of the difference between a function of respiratory airflow over a period of time and a target value that is an alveolar ventilation which takes into account the patient's physiologic dead space, and a control mechanism (15) for causing a blower to deliver air to the patient at a pressure that is a function of said difference measure. The control mechanism (15) can operate a servo-controlled loop whose gain increases with the magnitude of said difference measure.
Patent NZ-594768-A (NZ)
Title: Bicyclic heterocyclic spiro compounds
Inventor: FISHER ABRAHAM
IPC: C07D495/10
Filed: 2010-01-26
Abstract: Disclosed herein are bicyclic heterocyclic spiro compounds of formula I, wherein the substituents are as defined in the specification, compositions comprising said compounds, processes for their preparation and uses thereof. Said compounds are useful ligands for G-protein coupled receptors (GPCRs) and are particularly useful as muscarinic receptor agonists as such are useful in the treatment of conditions such as insulin resistance syndrome, type 2 diabetes, Alzheimer's disease. Examples of particularly preferred compounds include: (1-(2,8-dimethyl-1-thia-3,8-diazaspiro[4.5]dec-3-yl)-3-(1H-indol-3-yl)propan-1-one); 1-(2,8-Dimethyl-1-thia-3,8-diazaspiro[4.5]dec-3-yl)-3-(1-methyl-indol-3-yl)propan-1-one; (3-(4-fluorobenzenesulfonyl)-2,8-dimethyl-1-thia-3,8-diazaspiro[4.5]-decane); 1-(2,8-dimethyl-1-oxa-3,8-diazaspiro[4.5]dec-3-yl)-3-(1H-indol-3-yl)-propan-1-one; (1-(2,8-dimethyl-1-oxa-4,8-diazaspiro[4.5]dec-4-yl)-3-(1H-indol-3-yl)-propan-1-one); (1',4-dimethyl-6-(3-indolpropionyl)-spiro-(3-oxa-6-aza-bicyclo[3.1.]-hexane-2,4 '-piperidine)); (1',4-dimethyl-6-[3-(4-fluorobenzenesulfonyl)]-spiro-(3-oxa-6-aza-bicycl 0[3.1.0]hexane-2,4'-piperidine)); N-(2,8-dimethyl-1-oxa-8-aza-spiro[4.5]dec-3-yl)-3-(1H-indol-3-yl)-propionamide; N-(2,8-Dimethyl-1-thia-8-aza-spiro[4.5]dec-3-yl)-3-(1H-indol-3-yl)-propionamide, and (3E)-2,8-dimethyl-1-oxa-8-aza-spiro[4.5]decan-3-one-O-[3-(1H-indol-3-yl)propanoyI]oxime.
Patent NZ-597893-A (NZ)
Title: Fluorinated derivatives of 3-hydroxypyridin-4-ones
Inventor: TAM TIM FAT
IPC: C07D213/69
Filed: 2010-07-05
Abstract: Disclosed are are compounds of Formula I which are derivatives of 3-Hydroxypyridin-4-ones. The compounds may be used in treatment of a medical condition related to a toxic concentration of iron. The compounds may be used for preparation of a medicament for treatment of a medical condition related to a toxic concentration of iron. The medical condition related to a toxic concentration of iron may be selected from the group consisting of: cancer, pulmonary disease, progressive kidney disease and Frederich's Ataxia.
Patent NZ-598728-A (NZ)
Title: Compositions comprising bile acid sequestrants for treating esophageal disorders
Inventor: CURRIE MARK G
IPC: A61K9/00
Filed: 2007-12-21
Abstract: 598728 Disclosed is a sustained-release pharmaceutical dosage form adapted for oral administration to a subject in need thereof comprising a therapeutically effective amount of at least one bile acid sequestrant selected from colesevelam, colesevelam hydrochloride and sevelamer, a therapeutically effective amount of at least one proton pump inhibitor, and a gastric-retention vehicle composition comprising one or more hydrogels, wherein said dosage form is adapted for use in preventing or treating an upper GI disorder selected from dyspepsia, erosive esophagitis, GERD, esophagitis, Barrett's esophagus, esophageal adenocarcinoma, pharyngitis and GERD-related pulmonary dysfunctions. Examples of proton pump inhibitors are: omeprazole, esomeprazole, lansoprazole, pantoprazole, rabeprazole, tenatoprazole, leminoprazole, dontoprazole, and ransoprazole.
Patent NZ-599996-A (NZ)
Title: A pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent
Inventor: KENYON JULIAN NORMAN
IPC: A61K31/095
Filed: 2010-10-22
Abstract: Disclosed is a pharmaceutical composition comprising the protease proenzymes trypsinogen and chymotrypsinogen. The composition may further comprise an active agent is selected from at least one of a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent, and optionally a glycoside hydrolase. The vanilloid compound may be capsiate, namely 4-hydroxy-3-methoxybenzyl-(E)-8-methyl-6-nonenoate, the glycoside hydrolase may be a-amylase and the cytoplasmic glycolysis reduction agent may be 2-deoxy-D-glucose. The disclosure also relates to the use of the composition for the treatment of cancer.
Patent NZ-607661-A (NZ)
Title: Self-expandable biopolymer-mineral composite
Inventor: LI SHU-TUNG
IPC: A61L27/46
Filed: 2011-07-28
Abstract: NZ 607661 Disclosed is a compressed implant composite for repairing mineralised tissue, the composite comprising: a cross-linked matrix formed of biopolymeric fibres; and a plurality of calcium- or silicate-based mineral particles dispersed in the matrix, wherein, the matrix constitutes 4 to 80% by weight, the mineral particles constitute 20 to 96% by weight; the composite is free of soluble collagen and is self-expandable to a volume 2 to 100 times of its compressed volume.